New Zealand - English - Medsafe (Medicines Safety Authority)

apotex nz ltd - risperidone 1mg;   - film coated tablet - 1 mg - active: risperidone 1mg   excipient: hyprolose hypromellose lactose monohydrate macrogol 8000 magnesium stearate maize starch microcrystalline cellulose titanium dioxide - apo-risperidone is indicated for the treatment of schizophrenia and other psychotic disorders. these include first episode psychoses, acute schizophrenic exacerbations, chronic schizophrenia and other psychotic conditions, in which positive symptoms (such as hallucinations, delusions, thought disturbances, hostility, suspiciousness), and/or negative symptoms (such as blunted effect, emotional and social withdrawal, poverty of speech) are prominent.

New Zealand - English - Medsafe (Medicines Safety Authority)

apotex nz ltd - risperidone 1 mg/ml - oral solution - 1 mg/ml - active: risperidone 1 mg/ml excipient: benzoic acid purified water sodium hydroxide sorbitol tartaric acid - apo-risperidone is indicated for the treatment of schizophrenia and other psychotic disorders. these include first episode psychoses, acute schizophrenic exacerbations, chronic schizophrenia and other psychotic conditions, in which positive symptoms (such as hallucinations, delusions, thought disturbances, hostility, suspiciousness), and/or negative symptoms (such as blunted effect, emotional and social withdrawal, poverty of speech) are prominent. apo-risperidone also alleviates affective symptoms (such as depression, guilt-feelings, anxiety) associated with schizophrenia. in addition, apo-risperidone also appears effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial response to treatment with this agent.

Canada - English - Health Canada

jamp pharma corporation - risperidone (risperidone tartrate) - solution - 1mg - risperidone (risperidone tartrate) 1mg - atypical antipsychotics

Canada - English - Health Canada

avanstra inc - risperidone (risperidone tartrate) - solution - 1mg - risperidone (risperidone tartrate) 1mg - atypical antipsychotics

Canada - English - Health Canada

pharmascience inc - risperidone (risperidone tartrate) - solution - 1mg - risperidone (risperidone tartrate) 1mg - atypical antipsychotics

United States - English - NLM (National Library of Medicine)

breckenridge pharmaceutical, inc. - risperidone (unii: l6uh7zf8hc) (risperidone - unii:l6uh7zf8hc) - risperidone 1 mg in 1 ml - risperidone oral solution is indicated for the treatment of schizophrenia. efficacy was established in 4 short-term trials in adults, 2 short-term trials in adolescents (ages 13 to 17 years), and one long-term maintenance trial in adults [see clinical studies (14.1) ]. monotherapy risperidone oral solution is indicated for the treatment of acute manic or mixed episodes associated with bipolar i disorder. efficacy was established in 2 short-term trials in adults and one short-term trial in children and adolescents (ages 10 to 17 years) [see clinical studies (14.2) ]. adjunctive therapy risperidone oral solution adjunctive therapy with lithium or valproate is indicated for the treatment of acute manic or mixed episodes associated with bipolar i disorder. efficacy was established in one short-term trial in adults [see clinical studies (14.3) ]. risperidone oral solution is indicated for the treatment of irritability associated with autistic disorder, including symptoms of aggression towards others, deliberate se

United States - English - NLM (National Library of Medicine)

par pharmaceutical - risperidone (unii: l6uh7zf8hc) (risperidone - unii:l6uh7zf8hc) - risperidone 1 mg in 1 ml - risperidone oral solution is indicated for the treatment of schizophrenia. efficacy was established in 4 short-term trials in adults, 2 short-term trials in adolescents (ages 13 to 17 years), and one long-term maintenance trial in adults [see clinical studies (14.1) ]. monotherapy risperidone oral solution is indicated for the treatment of acute manic or mixed episodes associated with bipolar i disorder. efficacy was established in 2 short-term trials in adults and one short-term trial in children and adolescents (ages 10 to 17 years) [see clinical studies (14.2) ]. adjunctive therapy risperidone adjunctive therapy with lithium or valproate is indicated for the treatment of acute manic or mixed episodes associated with bipolar i disorder. efficacy was established in one short-term trial in adults [see clinical studies (14.3) ]. risperidone oral solution is indicated for the treatment of irritability associated with autistic disorder, including symptoms of aggression towards others, deliberate self-injur

United States - English - NLM (National Library of Medicine)

heritage pharmaceuticals inc. - risperidone (unii: l6uh7zf8hc) (risperidone - unii:l6uh7zf8hc) - risperidone 1 mg in 1 ml - risperidone is indicated for the treatment of schizophrenia. efficacy was established in 4 short-term trials in adults, 2 short-term trials in adolescents (ages 13 to 17 years), and one long-term maintenance trial in adults [see clinical studies (14.1) ]. monotherapy risperidone is indicated for the treatment of acute manic or mixed episodes associated with bipolar i disorder. efficacy was established in 2 short-term trials in adults and one short-term trial in children and adolescents (ages 10 to 17 years) [see clinical studies (14.2) ]. adjunctive therapy risperidone adjunctive therapy with lithium or valproate is indicated for the treatment of acute manic or mixed episodes associated with bipolar i disorder. efficacy was established in one short-term trial in adults [see clinical studies (14.3) ]. risperidone is indicated for the treatment of irritability associated with autistic disorder, including symptoms of aggression towards others, deliberate self-injuriousness, temper tantrums, and quickly changing

Canada - English - Health Canada

apotex inc - risperidone (risperidone tartrate) - solution - 1mg - risperidone (risperidone tartrate) 1mg - atypical antipsychotics

Canada - English - Health Canada

dominion pharmacal - risperidone (risperidone tartrate) - solution - 1mg - risperidone (risperidone tartrate) 1mg - atypical antipsychotics